Clinical Regimens of Favipiravir Inhibit Zika Virus Replication in the Hollow-Fiber Infection Model

Zika virus (ZIKV) infection is associated with serious, long-term neurological manifestations. There are currently no approved therapies for the treatment or prevention of ZIKV infection. Favipiravir (FAV) is a viral polymerase inhibitor with broad-spectrum activity. Our prior studies used static FA...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Antimicrob Agents Chemother
Huvudupphovsmän: Pires de Mello, Camilly P., Tao, Xun, Kim, Tae Hwan, Vicchiarelli, Michael, Bulitta, Jürgen B., Kaushik, Ajeet, Brown, Ashley N.
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 2018
Ämnen:
Antiviral Agents
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6125552/
https://ncbi.nlm.nih.gov/pubmed/29967017
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00967-18
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk